中東およびアフリカの医療用大麻市場
Market Size in USD Billion
CAGR :
% 
 予測期間 |
2024 –2030 |
 市場規模（基準年） |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| 主要市場プレーヤー |
>中東およびアフリカの医療用大麻市場、製品別（オイル、医療用大麻カプセル、パッチ、全花、粉末花、ベイプペン、乾燥医療用大麻、クリームと保湿剤、マスクと美容液、クレンザーなど）、原料別（天然および合成）、種別（インディカ大麻、サティバ大麻、ハイブリッド大麻）、用途別（アルツハイマー病、食欲不振、がん、炎症性腸疾患、摂食障害、てんかん、自閉症、精神疾患、多発性硬化症、疼痛管理、吐き気、筋けいれん、消耗症候群（悪液質）、気分高揚、うつ病および睡眠障害、不安など）、誘導体別（カンナビジオール（CBD）、テトラヒドロカンナビノール（THC）/デルタ-8-テトラヒドロカンナビノール、カンナビノール（CBN）、カンナビシクロル(CBL)、カンナビクロメン (CBC)、カンナビゲロール (CBG)、その他)、治療タイプ (去痰薬、抗ウイルス薬、鎮痛薬、媚薬、幻覚剤、その他)、投与経路 (経口液剤およびカプセル剤、喫煙、気化器、局所薬、その他)、エンドユーザー (製薬業界、研究開発センター、在宅ケア環境、病院、リハビリセンター、その他)、流通チャネル (B2B および B2C) - 2030 年までの業界動向と予測。
中東およびアフリカの医療用大麻市場の分析と洞察
中東およびアフリカにおける慢性疾患患者数の増加と健康的なライフスタイルへの傾向の高まりは、市場の成長を牽引すると予想される要因の一部です。さらに、医療用大麻機器の製品承認数の増加と研究開発活動の増加が市場の成長を牽引すると予想されます。ただし、医療用大麻機器と手順の高コスト、医薬品、レーザー手順に関連する安全性の懸念と副作用、レーザー機器による治療に関する認識の欠如が、市場の成長を抑制すると予想されます。医療用大麻のさらなる技術的進歩と新興企業による戦略的イニシアチブは、市場成長の機会として機能すると予想されます。ただし、厳格な規制と熟練した専門家の不足が市場の成長に対する課題となることが予想されます。
大麻の医薬品としての使用は、政府の規制により厳密にテストされておらず、医療および臨床用途における大麻の有効性を定義する臨床研究は限られています。しかし、予備研究では、大麻は化学療法患者の嘔吐や吐き気を軽減し、食欲を増進させる効果があることが示唆されています。
データブリッジ・マーケット・リサーチは、中東およびアフリカの医療用大麻市場は、2023年から2030年の予測期間中に21.7%のCAGRで成長すると予測していると分析しています。
|
レポートメトリック |
詳細 |
|
予測期間 |
2023年から2030年 |
|
基準年 |
2022 |
|
歴史的な年 |
2021 (2015～2020年にカスタマイズ可能) |
|
定量単位 |
収益（百万米ドル） |
|
対象セグメント |
製品 (オイル、医療用大麻カプセル、パッチ、全花、粉末花、ベイプペン、乾燥医療用大麻、クリームと保湿剤、マスクと美容液、クレンザーなど)、原料 (天然および合成)、種 (大麻インディカ、サティバ、ハイブリッド)、用途 (アルツハイマー病、食欲不振、ガン、炎症性腸疾患、摂食障害、てんかん、自閉症、精神疾患、多発性硬化症、疼痛管理、吐き気、筋肉のけいれん、消耗症候群 (悪液質)、気分の高揚、うつ病および睡眠障害、不安など)、誘導体 (カンナビジオール (CBD)、テトラヒドロカンナビノール (THC)/デルタ-8-テトラヒドロカンナビノール、カンナビノール (CBN)、カンナビシクロール (CBL)、カンナビクロメン (CBC))、カンナビゲロール（CBG）など）、治療タイプ（去痰薬、抗ウイルス薬、鎮痛薬、媚薬、幻覚剤など）、投与経路（経口液剤およびカプセル剤、喫煙、気化器、外用薬など）、エンドユーザー（製薬業界、研究開発センター、在宅ケア環境、病院、リハビリセンターなど）、流通チャネル（B2BおよびB2C） |
|
対象国 |
イスラエル、南アフリカ、レバノン、UAE、クウェート、その他の中東およびアフリカ諸国 |
|
対象となる市場プレーヤー |
MediPharm Labs Inc.、Tilray、Aurora Cannabis、JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)、HEXO Corp. (Zenabis Middle East and Africa Ltd)、Cresco Labs、Peace Naturals Project Inc.、CANOPY GROWTH CORPORATION、Medical Marijuana, Inc.、Seed Cellar、EcoGen Biosciences、CANNABIS SEEDS USA、Seeds For Me、HUMBOLDT SEED COMPANY、Extractas、World Class Cannabis Seeds (Crop King Seeds)、BARNEY'S FARM、FOLIUM BIOSCIENCES、PharmaHemp、Elixinol Middle East and Africa Limited、ENDOCA、Harmony、MARY'S nutritionals, LLC、Pure Ratios、Greenwich Biosciences, Inc.、Upstate Elevator Supply Co.、Apothecanna、BOL Pharma、IDT Australia など |
市場の定義
大麻はアサ科の植物から抽出される向精神薬です。長年にわたり医療用として使用され、慢性疼痛、癌、うつ病、糖尿病、関節炎、緑内障、てんかん、偏頭痛、エイズ、アルツハイマー病など、さまざまな病気の治療に幅広く応用されています。
大麻の医療用途の増加、さまざまな業界での大麻の管理された合法化と使用、およびこの分野に存在する高度な方法論は、市場の成長を促進すると予想される要因の一部です。
中東およびアフリカの医療用大麻市場の動向
このセクションでは、市場の推進要因、利点、機会、制約、課題について理解します。これらはすべて、以下のように詳細に説明されます。
ドライバー
- 医薬品としての大麻の使用増加
医療用大麻は大麻植物から抽出され、特定の病状の症状や一部の治療の副作用の治療に使用できます。大麻の医療用途として最も一般的なのは、痛みの管理です。さまざまな適応症で大麻の使用を合法化する国が増え、医療用大麻は徐々に受け入れられ、使用されるようになっています。医療用大麻は、まれで重篤なてんかん、ドラベ症候群、レノックス・ガストー症候群の 3 つの適応症、および多発性硬化症 (MS) の痙縮の治療に FDA によって承認されています。
医療用マリファナは、承認された医薬品とは別に、病気や症状の治療にマリファナ植物またはその中の化学物質を使用しますが、デルタ-9-テトラヒドロカンナビノールとカンナビジオールという 2 つのカンナビノイドへの関心が高まっています。テトラヒドロカンナビノールは食欲を増進し、疲労を最小限に抑え、筋肉機能の問題を管理することが示されており、カンナビジオールはてんかん発作の管理、精神疾患の治療、炎症の軽減に効果的です。
- 大麻の合法化
医療用大麻の使用と受容は進化を続けており、特定の医療適応症の使用を許可する州が増えています。多くの国では医療目的または娯楽目的でマリファナを合法化していますが、使用を制限している国もあります。近年、米国では医療目的または娯楽目的でマリファナを合法化する州が増えています。大麻の合法化が広まるにつれ、多くの企業も積極的になり、大麻の完全合法化に向けた取り組みを行っています。
世界各地でマリファナが合法化されているのは、追加収入を増やすための取り組みと見ることができます。こうすることで、税金を上げずに収入を増やすことができます。大麻の合法化により、医療目的または娯楽目的での大麻の消費が増えることになります。さらに、大麻ビジネスも促進され、大麻の需要が高まります。したがって、大麻の合法化は市場の成長を促進すると予想されます。
機会
- 研究開発活動の増加による新製品開発
医療用大麻には、カプセル、チューイングガム、クリーム、結晶、花、トローチ、オイル、口腔粘膜スプレーなど、さまざまな形態があります。合法化に伴う大麻の需要の急成長により、より優れた製品株とデリバリーシステムの開発の必要性が高まっています。このため、多くの企業が大麻の遺伝的改良戦略を確認するための研究開発活動を行っています。FDA の大麻製品委員会 (CPC) は、大麻製品の規制に関する省庁横断的な戦略とポリシーを策定し、実施しています。開発され、増加している新しい製品は、ヘンププロテインパウダー、エナジーバー、ヘンプミルク、ヘンプフラワー、ヘンプティーで、市場成長の機会を生み出すことが期待されています。
- 娯楽目的での大麻の採用増加
娯楽用マリファナの合法化は、潜在的な悪影響を増やすことなく、安全な薬物の規制に役立ちます。マリファナの合法化は、税金を増やすことなく経済を成長させ、何千もの雇用機会を創出し、マリファナの取り締まりにおける人種の違いをなくし、希少な警察資源を解放するなど、さまざまな社会的利益をもたらします。娯楽用マリファナの合法化は、費用のかかるマリファナ法の取り締まりを終わらせ、違法マリファナ市場を弱体化させることができます。
これらの利点により、マリファナは合法化され、さまざまな年齢層の人々にますます受け入れられています。これにより、楽しみとリラクゼーションのための良質のマリファナの需要が生まれます。したがって、娯楽目的での大麻の採用の増加は、市場でメーカーにチャンスを生み出すと予想されます。
抑制/挑戦
- 高額な購入と高品質への急ぎ
医療用大麻デバイスは製造と購入に費用がかかる場合があり、特殊な機器とトレーニングが必要なため、処置費用も高額になる可能性があります。これにより、特に低所得地域では、患者と医療施設が医療用大麻治療を受けにくくなる可能性があります。さらに、医療用大麻デバイスと処置の費用が高いため、特に自費で支払わなければならない場合、一部の患者はこれらの治療を選択することを思いとどまる可能性があります。医療用大麻治療に対する保険適用も限られているため、採用が制限される可能性があります。
その結果、医療用大麻の機器や処置にかかるコストの高さは、特にコストが大きな要因となっている地域では、市場の成長に対する大きな障壁となる可能性があります。しかし、技術が進歩するにつれて、これらの機器や処置にかかるコストは下がり、患者や医療施設にとってより利用しやすくなる可能性があります。
医療用大麻機器の複雑化と医療用大麻治療の高コストにより、市場の成長が抑制されると予想されます。
最近の開発
- 2018 年 5 月、カナダ政府の大麻法に基づき、大麻法により、カナダ全土での大麻の生産、流通、販売、所持を規制するための厳格な法的枠組みが構築されます。これは、法的に規制された強固な産業を育成することで、大麻が若者の手に渡らないようにし、組織犯罪の利益が大麻に流れないようにすることを目的としています。
中東およびアフリカの医療用大麻市場の範囲
中東およびアフリカの医療用大麻市場は、製品、供給源、種、派生物、用途、投与経路、治療タイプ、エンドユーザー、流通チャネルに基づいて、9 つの主要なセグメントに分割されています。これらのセグメントの成長は、業界の市場成長セグメントの分析に役立ち、ユーザーに貴重な市場概要と市場洞察を提供して、コア市場アプリケーションを特定するための戦略的決定を下すのに役立ちます。
製品
- 油
- 乾燥医療用大麻
- 医療用大麻カプセル
- ベイプペン
- 花全体
- クリーム＆保湿剤
- グラウンドフラワー
- パッチ
- マスク＆美容液
- クレンザー
- その他
製品に基づいて、市場はオイル、医療用大麻カプセル、パッチ、全花、粉末花、ベイプペン、乾燥医療用大麻、クリームと保湿剤、マスクと美容液、クレンザー、その他に分類されます。
ソース
- 合成
- 自然
供給源に基づいて、市場は合成と天然に分類されます。
種
- 大麻インディカ
- サティバ
- ハイブリッド
種に基づいて、市場は大麻のインディカ、サティバ、ハイブリッドに分類されます。
デリバティブ
- カンナビジオール（CBD）
- テトラヒドロカンナビノール (THC)/デルタ-8-テトラヒドロカンナビノール
- カンナビゲロール（CBG）
- カンナビクロメン（CBC）
- カンナビノール（CBN）
- カンナビシクロロール (CBL)
- その他
誘導体に基づいて、市場はカンナビジオール（CBD）、テトラヒドロカンナビノール（THC）/デルタ-8-テトラヒドロカンナビノール、カンナビノール（CBN）、カンナビシクロール（CBL）、カンナビクロメン（CBC）、カンナビゲロール（CBG）などに分類されます。
応用
- 疼痛管理
- 不安
- 筋けいれん
- 吐き気
- 食欲不振
- 摂食障害
- 炎症性腸疾患
- 癌
- 関節炎
- 消耗症候群（悪液質）
- アルツハイマー病
- てんかん
- うつ病と睡眠障害
- 多発性硬化症
- 自閉症
- 精神衛生状態
- 気分を高める
- その他
用途に基づいて、市場はアルツハイマー病、食欲不振、癌、炎症性腸疾患、摂食障害、てんかん、自閉症、精神疾患、多発性硬化症、疼痛管理、吐き気、筋肉のけいれん、消耗症候群（悪液質）、気分の高揚、多発性硬化症、うつ病および睡眠障害、不安症などに分類されます。
投与経路
- 経口液剤とカプセル剤
- 喫煙
- 気化器
- 局所用薬
- その他
投与経路に基づいて、市場は経口液剤とカプセル剤、喫煙、気化器、局所薬、その他に分類されます。
治療の種類
- 鎮痛剤
- サイケデリック
- 抗ウィルス薬
- 媚薬
- 去痰薬
- その他
治療の種類に基づいて、市場は去痰薬、抗ウイルス薬、鎮痛薬、媚薬、幻覚剤、その他に分類されます。
エンドユーザー
- 在宅ケア環境
- 病院
- リハビリセンター
- 製薬業界
- 研究開発センター
- その他
エンドユーザーに基づいて、市場は製薬業界、研究開発センター、在宅ケア環境、病院、リハビリセンター、その他に分類されます。
流通チャネル
- 企業向け
- B2C
流通チャネルに基づいて、市場は B2B と B2C に分類されます。
中東およびアフリカの医療用大麻市場の地域分析/洞察
中東およびアフリカの医療用大麻市場は、製品、供給元、種、派生物、用途、投与経路、治療タイプ、エンドユーザー、流通チャネルに基づいて、9 つの主要なセグメントに分割されています。
この市場レポートで取り上げられている国は、イスラエル、南アフリカ、レバノン、UAE、クウェート、およびその他の中東およびアフリカ諸国です。
イスラエルは、国内での研究開発活動の増加により、中東およびアフリカの医療用大麻市場を支配すると予想されています。
レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、地域ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面する課題、販売チャネルの影響も考慮されます。
競争環境と中東・アフリカの医療用大麻市場シェア分析
中東およびアフリカの医療用大麻市場の競争状況は、競合他社の詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、地域でのプレゼンス、生産拠点と施設、会社の強みと弱み、製品の発売、臨床試験パイプライン、ブランド分析、製品の承認、特許、製品の幅と広さ、アプリケーションの優位性、および技術ライフライン曲線が含まれます。提供された上記のデータ ポイントは、市場に関連する会社の焦点にのみ関連しています。
この市場で活動している主要な市場プレーヤーには、MediPharm Labs Inc.、Tilray、Aurora Cannabis、JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc)、HEXO Corp. (Zenabis Middle East and Africa Ltd)、Cresco Labs、Peace Naturals Project Inc.、CANOPY GROWTH CORPORATION、Medical Marijuana, Inc.、Seed Cellar、EcoGen Biosciences、CANNABIS SEEDS USA、Seeds For Me、HUMBOLDT SEED COMPANY、Extractas、World Class Cannabis Seeds (Crop King Seeds)、BARNEY'S FARM、FOLIUM BIOSCIENCES、PharmaHemp、Elixinol Middle East and Africa Limited、ENDOCA、Harmony、MARY'S nutritionals, LLC、Pure Ratios、Greenwich Biosciences, Inc.、Upstate Elevator Supply Co.、Apothecanna、BOL Pharma、IDT Australia などがあります。
SKU-
世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする
- インタラクティブなデータ分析ダッシュボード
- 成長の可能性が高い機会のための企業分析ダッシュボード
- カスタマイズとクエリのためのリサーチアナリストアクセス
- インタラクティブなダッシュボードによる競合分析
- 最新ニュース、更新情報、トレンド分析
- 包括的な競合追跡のためのベンチマーク分析のパワーを活用
目次
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 INDUSTRY INSIGHTS
5.1 INDUSTRY INSIGHTS PATENT ANALYSIS
5.2 DRUG TREATMENT RATE BY MATURED MARKETS
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
5.4 PATIENT FLOW DIAGRAM
5.5 KEY PRICING STRATEGIES
5.6 KEY PATIENT ENROLLMENT STRATEGIES
6 REGULATORY SCENARIO
6.1 SOUTH AFRICA
6.2 U.A.E.
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED USE OF CANNABIS IN MEDICINES
7.1.2 LEGALIZATION OF CANNABIS
7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS
7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS
7.2 RESTRAINTS
7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS
7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE
7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY
7.3 OPPORTUNITIES
7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES
7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES
7.3.3 GROWING GERIATRIC POPULATION
7.4 CHALLENGES
7.4.1 RISE OF THE CANNABIS BLACK MARKET
7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS
7.4.3 SHORTAGE OF SKILLED PERSONNEL
8 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 OIL
8.2.1 OIL, BY TYPE
8.2.1.1 CBD OIL CONCENTRATES
8.2.1.2 CBD VAPE OIL
8.2.1.3 CBD TINCTURES
8.2.2 OIL, BY SOURCE
8.2.2.1 HEMP BASED
8.2.2.2 MARIJUANA BASED
8.2.3 OIL, BY SPECIES
8.2.3.1 SATIVA
8.2.3.2 HYBRID
8.2.3.3 CANNABIS INDICA
8.2.4 OIL, BY PRODUCT TYPE
8.2.4.1 BRANDED
8.2.4.1.1 PENGUIN CBD OIL
8.2.4.1.2 FAB CBD OIL
8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL
8.2.4.1.4 OTHERS
8.2.4.2 GENERIC
8.3 DRIED MEDICAL CANNABIS
8.3.1 CANNABIS INDICA
8.3.2 SATIVA
8.3.3 HYBRID
8.4 MEDICAL CANNABIS CAPSULES
8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE
8.4.1.1 OIL BASED CANNABIS CAPSULES
8.4.1.2 POWDER BASED CANNABIS CAPSULES
8.4.1.3 LIQUID BASED CANNABIS CAPSULES
8.4.1.4 OTHERS
8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES
8.4.2.1 HIGH CBD CAPSULES DIGITAL
8.4.2.2 HIGH THC CAPSULE
8.4.2.3 THC/CBD BALANCED CAPSULE
8.4.2.4 CBD ISOLATE CAPSULE
8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES
8.4.3.1 SATIVA
8.4.3.2 CANNABIS INDICA
8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE
8.4.4.1 BRANDED
8.4.4.1.1 JOY NUTRITION
8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES
8.4.4.1.3 LAZARUS NATURALS
8.4.4.1.4 OTHERS
8.4.4.2 GENERIC
8.5 VAPE PEN
8.5.1 VAPE PEN, BY SPECIES
8.5.1.1 SATIVA
8.5.1.2 HYBRID
8.5.1.3 CANNABIS INDICA
8.5.2 VAPE PEN, BY PRODUCT TYPE
8.5.2.1 BRANDED
8.5.2.1.1 KANDYPENS RUBI
8.5.2.1.2 SOL E-NECTAR COLLECTOR
8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN
8.5.2.2 GENERIC
8.6 WHOLE FLOWER
8.6.1 WHOLE FLOWER, SPECIES
8.6.1.1 SATIVA
8.6.1.2 HYBRID
8.6.1.3 CANNABIS INDICA
8.6.2 WHOLE FLOWER, PRODUCT TYPE
8.6.2.1 BRANDED
8.6.2.1.1 ASTER FARMS
8.6.2.1.2 RA FLOWER
8.6.2.1.3 BAD APPLE
8.6.2.2 GENERIC
8.7 CREAMS & MOISTURIZER
8.7.1 CREAMS & MOISTURIZER, BY SPECIES
8.7.1.1 SATIVA
8.7.1.2 HYBRID
8.7.1.3 CANNABIS INDICA
8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE
8.7.2.1 BRANDED
8.7.2.1.1 CBDFX MUSCLE & JOINT
8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM
8.7.2.1.3 MEDTERRA PAIN CREAM
8.7.2.2 GENERIC
8.8 GROUND FLOWER
8.8.1 GROUND FLOWER, BY SPECIES
8.8.1.1 SATIVA
8.8.1.2 HYBRID
8.8.1.3 CANNABIS INDICA
8.8.2 GROUND FLOWER, BY PRODUCT TYPE
8.8.2.1 BRANDED
8.8.2.1.1 ASTER FARMS
8.8.2.1.2 RA FLOWER
8.8.2.1.3 BAD APPLE
8.8.2.2 GENERIC
8.9 PATCH
8.9.1 PATCH, BY TYPE
8.9.1.1 RESERVOIR
8.9.1.2 LAYER DRUG-IN-ADHESIVE
8.9.1.3 OTHERS
8.9.2 PATCH, BY SPECIES
8.9.2.1 SATIVA
8.9.2.2 CANNABIS INDICA
8.9.2.3 HYBRID
8.9.3 PATCH, BY PRODUCT TYPE
8.9.3.1 BRANDED
8.9.3.1.1 HEMP BOMBS
8.9.3.1.2 PUREKANA
8.9.3.1.3 PURE RATIOS
8.9.3.1.4 RESERVOIR
8.9.3.2 GENERIC
8.1 MASKS & SERUM
8.10.1 MASKS & SERUM, BY SPECIES
8.10.1.1 SATIVA
8.10.1.2 CANNABIS INDICA
8.10.1.3 HYBRID
8.10.2 MASKS & SERUM, BY PRODUCT TYPE
8.10.2.1 BRANDED
8.10.2.1.1 BUMP & SMOOTH CBD
8.10.2.1.2 FACIAL ESSENCE
8.10.2.1.3 OTHERS
8.10.2.2 GENERIC
8.11 CLEANSER
8.11.1 CLEANSER, BY SPECIES
8.11.1.1 SATIVA
8.11.1.2 HYBRID
8.11.1.3 CANNABIS INDICA
8.11.2 CLEANSER, BY PRODUCT TYPE
8.11.2.1 BRANDED
8.11.2.1.1 KIEHL’S
8.11.2.1.2 CBD 101
8.11.2.1.3 OTHERS
8.11.2.2 GENERIC
8.12 OTHERS
9 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY SPECIES
9.1 OVERVIEW
9.2 SATIVA
9.3 HYBRID
9.4 CANNABIS INDICA
10 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES
10.1 OVERVIEW
10.2 CANNABIDIOL (CBD)
10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL
10.4 CANNABIGEROL (CBG)
10.5 CANNABICHROMENE (CBC)
10.6 CANNABINOL (CBN)
10.7 CANNABICYCLOL (CBL)
10.8 OTHERS
11 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 PAIN MANAGEMENT
11.2.1 PAIN MANAGEMENT, BY TYPE
11.2.1.1 CHRONIC PAIN
11.2.1.2 NON-CANCER CHRONIC PAIN
11.2.1.3 NEUROLOGICAL PAIN
11.2.2 PAIN MANAGEMENT, BY PRODUCT
11.2.2.1 OIL
11.2.2.2 DRIED MEDICAL CANNABIS
11.2.2.3 MEDICAL CANNABIS CAPSULES
11.2.2.4 PATCH
11.2.2.5 GROUND FLOWER
11.2.2.6 CREAMS & MOISTURIZER
11.2.2.7 VAPE PEN
11.2.2.8 WHOLE FLOWER
11.2.2.9 MASKS & SERUM
11.2.2.10 CLEANSER
11.2.2.11 OTHERS
11.3 ANXIETY
11.3.1 OIL
11.3.2 DRIED MEDICAL CANNABIS
11.3.3 MEDICAL CANNABIS CAPSULES
11.3.4 PATCH
11.3.5 GROUND FLOWER
11.3.6 CREAMS & MOISTURIZER
11.3.7 VAPE PEN
11.3.8 WHOLE FLOWER
11.3.9 MASKS & SERUM
11.3.10 CLEANSER
11.3.11 OTHERS
11.4 MUSCLE SPASM
11.4.1 OIL
11.4.2 DRIED MEDICAL CANNABIS
11.4.3 MEDICAL CANNABIS CAPSULES
11.4.4 PATCH
11.4.5 GROUND FLOWER
11.4.6 CREAMS & MOISTURIZER
11.4.7 VAPE PEN
11.4.8 WHOLE FLOWER
11.4.9 MASKS & SERUM
11.4.10 CLEANSER
11.4.11 OTHERS
11.5 NAUSEA
11.5.1 OIL
11.5.2 DRIED MEDICAL CANNABIS
11.5.3 MEDICAL CANNABIS CAPSULES
11.5.4 PATCH
11.5.5 GROUND FLOWER
11.5.6 CREAMS & MOISTURIZER
11.5.7 VAPE PEN
11.5.8 WHOLE FLOWER
11.5.9 MASKS & SERUM
11.5.10 CLEANSER
11.5.11 OTHERS
11.6 APPETITE LOSS
11.6.1 OIL
11.6.2 DRIED MEDICAL CANNABIS
11.6.3 MEDICAL CANNABIS CAPSULES
11.6.4 PATCH
11.6.5 GROUND FLOWER
11.6.6 CREAMS & MOISTURIZER
11.6.7 VAPE PEN
11.6.8 WHOLE FLOWER
11.6.9 MASKS & SERUM
11.6.10 CLEANSER
11.6.11 OTHERS
11.7 EATING DISORDERS
11.7.1 OIL
11.7.2 DRIED MEDICAL CANNABIS
11.7.3 MEDICAL CANNABIS CAPSULES
11.7.4 PATCH
11.7.5 GROUND FLOWER
11.7.6 CREAMS & MOISTURIZER
11.7.7 VAPE PEN
11.7.8 WHOLE FLOWER
11.7.9 MASKS & SERUM
11.7.10 CLEANSER
11.7.11 OTHERS
11.8 INFLAMMATORY BOWEL DISEASES
11.8.1 OIL
11.8.2 DRIED MEDICAL CANNABIS
11.8.3 MEDICAL CANNABIS CAPSULES
11.8.4 PATCH
11.8.5 GROUND FLOWER
11.8.6 CREAMS & MOISTURIZER
11.8.7 VAPE PEN
11.8.8 WHOLE FLOWER
11.8.9 MASKS & SERUM
11.8.10 CLEANSER
11.8.11 OTHERS
11.9 CANCER
11.9.1 OIL
11.9.2 DRIED MEDICAL CANNABIS
11.9.3 MEDICAL CANNABIS CAPSULES
11.9.4 PATCH
11.9.5 GROUND FLOWER
11.9.6 CREAMS & MOISTURIZER
11.9.7 VAPE PEN
11.9.8 WHOLE FLOWER
11.9.9 MASKS & SERUM
11.9.10 CLEANSER
11.9.11 OTHERS
11.1 ARTHRITIS
11.10.1 OIL
11.10.2 DRIED MEDICAL CANNABIS
11.10.3 MEDICAL CANNABIS CAPSULES
11.10.4 PATCH
11.10.5 GROUND FLOWER
11.10.6 CREAMS & MOISTURIZER
11.10.7 VAPE PEN
11.10.8 WHOLE FLOWER
11.10.9 MASKS & SERUM
11.10.10 CLEANSER
11.10.11 OTHERS
11.11 WASHING SYNDROME (CACHEXIA)
11.11.1 OIL
11.11.2 DRIED MEDICAL CANNABIS
11.11.3 MEDICAL CANNABIS CAPSULES
11.11.4 PATCH
11.11.5 GROUND FLOWER
11.11.6 CREAMS & MOISTURIZER
11.11.7 VAPE PEN
11.11.8 WHOLE FLOWER
11.11.9 MASKS & SERUM
11.11.10 CLEANSER
11.11.11 OTHERS
11.12 ALZHEIMER’S DISEASE
11.12.1 OIL
11.12.2 DRIED MEDICAL CANNABIS
11.12.3 MEDICAL CANNABIS CAPSULES
11.12.4 PATCH
11.12.5 GROUND FLOWER
11.12.6 CREAMS & MOISTURIZER
11.12.7 VAPE PEN
11.12.8 WHOLE FLOWER
11.12.9 MASKS & SERUM
11.12.10 CLEANSER
11.12.11 OTHERS
11.13 EPILEPSY
11.13.1 OIL
11.13.2 DRIED MEDICAL CANNABIS
11.13.3 MEDICAL CANNABIS CAPSULES
11.13.4 PATCH
11.13.5 GROUND FLOWER
11.13.6 CREAMS & MOISTURIZER
11.13.7 VAPE PEN
11.13.8 WHOLE FLOWER
11.13.9 MASKS & SERUM
11.13.10 CLEANSER
11.13.11 OTHERS
11.14 DEPRESSION AND SLEEP DISORDER
11.14.1 OIL
11.14.2 DRIED MEDICAL CANNABIS
11.14.3 MEDICAL CANNABIS CAPSULES
11.14.4 PATCH
11.14.5 GROUND FLOWER
11.14.6 CREAMS & MOISTURIZER
11.14.7 VAPE PEN
11.14.8 WHOLE FLOWER
11.14.9 MASKS & SERUM
11.14.10 CLEANSER
11.14.11 OTHERS
11.15 MULTIPLE SCLEROSIS
11.15.1 OIL
11.15.2 DRIED MEDICAL CANNABIS
11.15.3 MEDICAL CANNABIS CAPSULES
11.15.4 PATCH
11.15.5 GROUND FLOWER
11.15.6 CREAMS & MOISTURIZER
11.15.7 VAPE PEN
11.15.8 WHOLE FLOWER
11.15.9 MASKS & SERUM
11.15.10 CLEANSER
11.15.11 OTHERS
11.16 AUTISM
11.16.1 OIL
11.16.2 DRIED MEDICAL CANNABIS
11.16.3 MEDICAL CANNABIS CAPSULES
11.16.4 PATCH
11.16.5 GROUND FLOWER
11.16.6 CREAMS & MOISTURIZER
11.16.7 VAPE PEN
11.16.8 WHOLE FLOWER
11.16.9 MASKS & SERUM
11.16.10 CLEANSER
11.16.11 OTHERS
11.17 MENTAL HEALTH CONDITIONS
11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE
11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD)
11.17.1.2 SCHIZOPHRENIA
11.17.1.3 OTHERS
11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE
11.17.2.1 OIL
11.17.2.2 DRIED MEDICAL CANNABIS
11.17.2.3 MEDICAL CANNABIS CAPSULES
11.17.2.4 PATCH
11.17.2.5 GROUND FLOWER
11.17.2.6 CREAMS & MOISTURIZER
11.17.2.7 VAPE PEN
11.17.2.8 WHOLE FLOWER
11.17.2.9 MASKS & SERUM
11.17.2.10 CLEANSER
11.17.2.11 OTHERS
11.18 ELEVATE MOOD
11.18.1 OIL
11.18.2 DRIED MEDICAL CANNABIS
11.18.3 MEDICAL CANNABIS CAPSULES
11.18.4 PATCH
11.18.5 GROUND FLOWER
11.18.6 CREAMS & MOISTURIZER
11.18.7 VAPE PEN
11.18.8 WHOLE FLOWER
11.18.9 MASKS & SERUM
11.18.10 CLEANSER
11.18.11 OTHERS
11.19 OTHERS
12 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 ORAL SOLUTIONS AND CAPSULES
12.3 SMOKING
12.4 TOPICALS
12.5 VAPORIZERS
12.6 OTHERS
13 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE
13.1 OVERVIEW
13.2 ANALGESIC
13.3 PSYCHEDELIC
13.4 ANTIVIRAL
13.5 APHRODISIAC
13.6 EXPECTORANT
13.7 OTHERS
14 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER
14.1 OVERVIEW
14.2 HOMECARE SETTING
14.3 HOSPITAL
14.4 REHAB CENTERS
14.5 PHARMACEUTICAL INDUSTRY
14.6 RESEARCH AND DEVELOPMENT CENTERS
14.7 OTHERS
15 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 B2C
15.2.1 PHARMACIES
15.2.2 CONVENTIONAL STORES
15.2.3 ONLINE STORES
15.2.4 OTHERS
15.3 B2B
16 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY REGION
16.1 MIDDLE EAST AND AFRICA
16.1.1 ISRAEL
16.1.2 SOUTH AFRICA
16.1.3 LEBANON
16.1.4 U.A.E.
16.1.5 KUWAIT
16.1.6 REST OF MIDDLE EAST AND AFRICA
17 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
18 COMPANY PROFILE
18.1 MEDIPHARM LABS INC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 TILRAY
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.3 AURORA CANNABIS
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 HEXO CORP. (ZENABIS MIDDLE EAST & AFRICA LTD)
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 APOTHECANNA
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 BOL PHARMA
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 BARNEY’S FARM
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 CANOPY GROWTH CORPORATION
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 CANNABIS SEEDS USA
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 CRESCO LABS
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENTS
18.12 ECOGEN BIOSCIENCES
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENTS
18.13 ELIXINOL MIDDLE EAST & AFRICA LIMITED
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 ENDOCA
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 EXTRACTAS
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 FOLIUM BIOSCIENCES
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 GREENWICH BIOSCIENCES, INC.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENTS
18.18 HARMONY
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENTS
18.19 HUMBOLDT SEED COMPANY
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.2 IDT AUSTRALIA
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENTS
18.21 MARY’S NUTRITIONALS, LLC
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
18.22 MEDICAL MARIJUANA, INC.
18.22.1 COMPANY SNAPSHOT
18.22.2 REVENUE ANALYSIS
18.22.3 PRODUCT PORTFOLIO
18.22.4 RECENT DEVELOPMENTS
18.23 PEACE NATURALS PROJECT INC.
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 PHARMAHEMP
18.24.1 COMPANY SNAPSHOT
18.24.2 PRODUCT PORTFOLIO
18.24.3 RECENT DEVELOPMENT
18.25 PURE RATIOS
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
18.26 SEEDS FOR ME
18.26.1 COMPANY SNAPSHOT
18.26.2 PRODUCT PORTFOLIO
18.26.3 RECENT DEVELOPMENT
18.27 SEED CELLAR
18.27.1 COMPANY SNAPSHOT
18.27.2 PRODUCT PORTFOLIO
18.27.3 RECENT DEVELOPMENT
18.28 UPSTATE ELEVATOR SUPPLY CO.
18.28.1 COMPANY SNAPSHOT
18.28.2 PRODUCT PORTFOLIO
18.28.3 RECENT DEVELOPMENT
18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS)
18.29.1 COMPANY SNAPSHOT
18.29.2 PRODUCT PORTFOLIO
18.29.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表のリスト
TABLE 1 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 43 MIDDLE EAST & AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 MIDDLE EAST & AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 47 MIDDLE EAST & AFRICA SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 MIDDLE EAST & AFRICA HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 MIDDLE EAST & AFRICA CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 51 MIDDLE EAST & AFRICA CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 MIDDLE EAST & AFRICA TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 MIDDLE EAST & AFRICA CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 MIDDLE EAST & AFRICA CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 55 MIDDLE EAST & AFRICA CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 MIDDLE EAST & AFRICA CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 60 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 MIDDLE EAST & AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 MIDDLE EAST & AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 63 MIDDLE EAST & AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 64 MIDDLE EAST & AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 65 MIDDLE EAST & AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 66 MIDDLE EAST & AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 67 MIDDLE EAST & AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 MIDDLE EAST & AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 MIDDLE EAST & AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 71 MIDDLE EAST & AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 MIDDLE EAST & AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 73 MIDDLE EAST & AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 MIDDLE EAST & AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 75 MIDDLE EAST & AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 MIDDLE EAST & AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 77 MIDDLE EAST & AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 MIDDLE EAST & AFRICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 79 MIDDLE EAST & AFRICA WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 80 MIDDLE EAST & AFRICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 81 MIDDLE EAST & AFRICA ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 82 MIDDLE EAST & AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 83 MIDDLE EAST & AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 84 MIDDLE EAST & AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 85 MIDDLE EAST & AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 87 MIDDLE EAST & AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 MIDDLE EAST & AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 89 MIDDLE EAST & AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 91 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 MIDDLE EAST & AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 96 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 97 MIDDLE EAST & AFRICA ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 98 MIDDLE EAST & AFRICA SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 99 MIDDLE EAST & AFRICA TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 100 MIDDLE EAST & AFRICA VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 101 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 102 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 103 MIDDLE EAST & AFRICA ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 104 MIDDLE EAST & AFRICA PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 105 MIDDLE EAST & AFRICA ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 106 MIDDLE EAST & AFRICA APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 107 MIDDLE EAST & AFRICA EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 108 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 109 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 MIDDLE EAST & AFRICA HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 111 MIDDLE EAST & AFRICA HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 112 MIDDLE EAST & AFRICA REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 113 MIDDLE EAST & AFRICA PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 114 MIDDLE EAST & AFRICA RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 115 MIDDLE EAST & AFRICA OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 MIDDLE EAST & AFRICA B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 120 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 121 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 124 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 125 MIDDLE EAST AND AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 MIDDLE EAST AND AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 130 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 131 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 134 MIDDLE EAST AND AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 137 MIDDLE EAST AND AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 MIDDLE EAST AND AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 140 MIDDLE EAST AND AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 141 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 143 MIDDLE EAST AND AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 146 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 147 MIDDLE EAST AND AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 MIDDLE EAST AND AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 150 MIDDLE EAST AND AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 MIDDLE EAST AND AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 153 MIDDLE EAST AND AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 154 MIDDLE EAST AND AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 155 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 156 MIDDLE EAST AND AFRICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 157 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 158 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 159 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 161 MIDDLE EAST AND AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 162 MIDDLE EAST AND AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 MIDDLE EAST AND AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 164 MIDDLE EAST AND AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 165 MIDDLE EAST AND AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 166 MIDDLE EAST AND AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 167 MIDDLE EAST AND AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 MIDDLE EAST AND AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 MIDDLE EAST AND AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 MIDDLE EAST AND AFRICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 171 MIDDLE EAST AND AFRICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 172 MIDDLE EAST AND AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 173 MIDDLE EAST AND AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 MIDDLE EAST AND AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 MIDDLE EAST AND AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 MIDDLE EAST AND AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 178 MIDDLE EAST AND AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 180 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 181 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 183 MIDDLE EAST AND AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 ISRAEL MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 185 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 186 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 187 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 188 ISRAEL OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 189 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 ISRAEL DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 191 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 192 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 193 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 194 ISRAEL MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 197 ISRAEL VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 200 ISRAEL WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 ISRAEL CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 203 ISRAEL CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 206 ISRAEL GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 210 ISRAEL PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 ISRAEL MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 213 ISRAEL MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 ISRAEL CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 216 ISRAEL CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 ISRAEL BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 ISRAEL MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 219 ISRAEL SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 220 ISRAEL MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 221 ISRAEL MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 222 ISRAEL MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 223 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 ISRAEL PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 225 ISRAEL ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 226 ISRAEL MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 ISRAEL NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 ISRAEL APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 229 ISRAEL EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 230 ISRAEL INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 231 ISRAEL CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 232 ISRAEL ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 233 ISRAEL WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 234 ISRAEL ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 ISRAEL EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 ISRAEL DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 ISRAEL MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 238 ISRAEL AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 239 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 ISRAEL MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 241 ISRAEL ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 242 ISRAEL MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 243 ISRAEL MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 244 ISRAEL MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 245 ISRAEL MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 246 ISRAEL B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 247 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 248 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 249 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 250 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 251 SOUTH AFRICA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 SOUTH AFRICA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 254 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 255 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 256 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 257 SOUTH AFRICA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 258 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 260 SOUTH AFRICA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 261 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 263 SOUTH AFRICA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 264 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 265 SOUTH AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 266 SOUTH AFRICA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 267 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 268 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 269 SOUTH AFRICA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 270 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 272 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 273 SOUTH AFRICA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 274 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 275 SOUTH AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 276 SOUTH AFRICA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 278 SOUTH AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 279 SOUTH AFRICA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 SOUTH AFRICA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 282 SOUTH AFRICA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 283 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 284 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 285 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 286 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 SOUTH AFRICA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 288 SOUTH AFRICA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 289 SOUTH AFRICA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 290 SOUTH AFRICA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 291 SOUTH AFRICA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 292 SOUTH AFRICA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 293 SOUTH AFRICA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 294 SOUTH AFRICA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 295 SOUTH AFRICA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 296 SOUTH AFRICA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 SOUTH AFRICA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 298 SOUTH AFRICA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 299 SOUTH AFRICA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 300 SOUTH AFRICA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 301 SOUTH AFRICA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 302 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 303 SOUTH AFRICA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 304 SOUTH AFRICA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 305 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 306 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 307 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 308 SOUTH AFRICA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 SOUTH AFRICA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 310 LEBANON MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 311 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 312 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 313 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 314 LEBANON OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 315 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 316 LEBANON DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 317 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 318 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 319 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 320 LEBANON MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 321 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 322 LEBANON VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 323 LEBANON VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 324 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 LEBANON WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 326 LEBANON WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 LEBANON CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 329 LEBANON CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 331 LEBANON GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 332 LEBANON GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 333 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 334 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 335 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 336 LEBANON PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 337 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 338 LEBANON MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 339 LEBANON MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 340 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 341 LEBANON CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 342 LEBANON CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 343 LEBANON BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 344 LEBANON MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 345 LEBANON SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 346 LEBANON MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 347 LEBANON MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 348 LEBANON MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 349 LEBANON PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 350 LEBANON PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 351 LEBANON ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 LEBANON MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 LEBANON NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 LEBANON APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 LEBANON EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 356 LEBANON INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 357 LEBANON CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 358 LEBANON ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 359 LEBANON WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 360 LEBANON ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 361 LEBANON EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 362 LEBANON DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 363 LEBANON MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 364 LEBANON AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 365 LEBANON MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 366 LEBANON MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 367 LEBANON ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 368 LEBANON MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 369 LEBANON MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 370 LEBANON MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 371 LEBANON MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 372 LEBANON B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 373 U.A.E. MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 374 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 375 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 376 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 377 U.A.E. OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 378 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 379 U.A.E. DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 380 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 381 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 382 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 383 U.A.E. MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 384 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 385 U.A.E. VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 386 U.A.E. VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 387 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 388 U.A.E. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 389 U.A.E. WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 390 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 391 U.A.E. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 392 U.A.E. CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 393 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 394 U.A.E. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 395 U.A.E. GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 397 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 398 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 399 U.A.E. PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 401 U.A.E. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 402 U.A.E. MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 403 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 404 U.A.E. CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 405 U.A.E. CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 406 U.A.E. BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 407 U.A.E. MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 408 U.A.E. SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 409 U.A.E. MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 410 U.A.E. MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 411 U.A.E. MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 412 U.A.E. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 413 U.A.E. PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 414 U.A.E. ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 415 U.A.E. MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 416 U.A.E. NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 417 U.A.E. APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 418 U.A.E. EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 419 U.A.E. INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 420 U.A.E. CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 421 U.A.E. ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 422 U.A.E. WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 423 U.A.E. ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 424 U.A.E. EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 425 U.A.E. DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 426 U.A.E. MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 427 U.A.E. AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 428 U.A.E. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 429 U.A.E. MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 430 U.A.E. ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 431 U.A.E. MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 432 U.A.E. MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 433 U.A.E. MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 434 U.A.E. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 435 U.A.E. B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 436 KUWAIT MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 437 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 438 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 439 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 440 KUWAIT OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 441 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 442 KUWAIT DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 443 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 444 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 445 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 446 KUWAIT MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 447 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 448 KUWAIT VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 449 KUWAIT VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 450 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 451 KUWAIT WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 452 KUWAIT WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 453 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 454 KUWAIT CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 455 KUWAIT CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 456 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 457 KUWAIT GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 458 KUWAIT GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 459 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 461 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 462 KUWAIT PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 464 KUWAIT MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 465 KUWAIT MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 466 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 467 KUWAIT CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 468 KUWAIT CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 469 KUWAIT BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 470 KUWAIT MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 471 KUWAIT SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 472 KUWAIT MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 473 KUWAIT MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 474 KUWAIT MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 475 KUWAIT PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 476 KUWAIT PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 477 KUWAIT ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 478 KUWAIT MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 479 KUWAIT NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 480 KUWAIT APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 481 KUWAIT EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 482 KUWAIT INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 483 KUWAIT CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 484 KUWAIT ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 485 KUWAIT WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 486 KUWAIT ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 487 KUWAIT EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 488 KUWAIT DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 489 KUWAIT MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 490 KUWAIT AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 491 KUWAIT MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 492 KUWAIT MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 493 KUWAIT ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 494 KUWAIT MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 495 KUWAIT MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 496 KUWAIT MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 497 KUWAIT MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 498 KUWAIT B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 499 REST OF MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
図表一覧
FIGURE 1 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: SEGMENTATION
FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET
FIGURE 14 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2022
FIGURE 15 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, 2022
FIGURE 19 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022
FIGURE 23 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION, 2022
FIGURE 27 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION , 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION , CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 31 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 34 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2022
FIGURE 35 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)
FIGURE 36 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, CAGR (2023-2030)
FIGURE 37 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 38 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, 2022
FIGURE 39 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 40 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 41 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 43 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 44 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 45 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: SNAPSHOT (2022)
FIGURE 47 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022)
FIGURE 48 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 49 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 50 MIDDLE EAST AND AFRICA MEDICAL CANNABIS MARKET: BY PRODUCT (2023-2030)
FIGURE 51 MIDDLE EAST & AFRICA MEDICAL CANNABIS MARKET: COMPANY SHARE 2022 (%)
調査方法
データ収集と基準年分析は、大規模なサンプル サイズのデータ収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。
DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。
カスタマイズ可能
Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。
